Literature DB >> 7803619

Regulation of prostaglandin synthesis by interleukin-1 beta in cultured bovine luteal cells.

D H Townson1, J L Pate.   

Abstract

Prostaglandins produced within the CL may serve as local modulators of CL function. The present study was designed to characterize the cellular mechanisms by which the cytokine interleukin-1 beta (IL-1 beta) stimulates prostaglandin production in cultured luteal cells. Cycloheximide (CHX) and actinomycin D (Act D) did not affect basal, but completely inhibited IL-1 beta-stimulated prostaglandin F2 alpha (PGF2 alpha) production (p < 0.05). The phospholipase A2 (PLA2) inhibitor, aristolochic acid (PLA2X), and the phospholipase C (PLC) inhibitor, compound 48/80 (PLCX), suppressed IL-1 beta-stimulated (p < 0.05), but not basal, PGF2 alpha production. The addition of exogenous arachidonic acid (AA) restored the stimulatory effect of IL-1 beta in PLCX-treated, but not in PLA2X-treated, cells, suggesting that PLA2 is a key regulatory point of IL-1 beta action. Chronic exposure of the luteal cells to IL-1 beta resulted in stimulatory effects beyond that of increasing AA availability, presumably by up-regulation of prostaglandin endoperoxide (PGH) synthase. Chronic exposure of luteal cells to IL-1 beta also inhibited progesterone production, but this effect appeared to be independent of endogenous PGF2 alpha production. The ability of IL-1 beta to comprehensively stimulate luteal PGF2 alpha production while inhibiting luteal progesterone production is suggestive that IL-1 beta may facilitate regression of the CL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803619     DOI: 10.1095/biolreprod51.3.480

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  8 in total

1.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

2.  A functional role for eicosanoid-lysophospholipids in activating monocyte signaling.

Authors:  Gao-Yuan Liu; Sung Ho Moon; Christopher M Jenkins; Harold F Sims; Shaoping Guan; Richard W Gross
Journal:  J Biol Chem       Date:  2020-07-08       Impact factor: 5.157

3.  The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process.

Authors:  S Kol; I Ben-Shlomo; K Ruutiainen; M Ando; T M Davies-Hill; R M Rohan; I A Simpson; E Y Adashi
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 4.  History, insights, and future perspectives on studies into luteal function in cattle.

Authors:  Cecily V Bishop; Vimal Selvaraj; David H Townson; Joy L Pate; Milo C Wiltbank
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

5.  Comparison of endocrine and cellular mechanisms regulating the corpus luteum of primates and ruminants.

Authors:  M C Wiltbank; S M Salih; M O Atli; W Luo; C L Bormann; J S Ottobre; C M Vezina; V Mehta; F J Diaz; S J Tsai; R Sartori
Journal:  Anim Reprod       Date:  2012-07       Impact factor: 1.807

6.  Expression of costimulatory molecules in the bovine corpus luteum.

Authors:  Matthew J Cannon; John S Davis; Joy L Pate
Journal:  Reprod Biol Endocrinol       Date:  2007-01-31       Impact factor: 5.211

Review 7.  The Role of Interleukins in Recurrent Implantation Failure: A Comprehensive Review of the Literature.

Authors:  Konstantinos Pantos; Sokratis Grigoriadis; Evangelos Maziotis; Kalliopi Pistola; Paraskevi Xystra; Agni Pantou; Georgia Kokkali; Athanasios Pappas; Maria Lambropoulou; Konstantinos Sfakianoudis; Mara Simopoulou
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

Review 8.  Regulation of intraluteal production of prostaglandins.

Authors:  Milo C Wiltbank; Joseph S Ottobre
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.